Labixiaoxin Snacks Group (1262) Fundamentals 2026 — P/E 49.8x, Revenue Analysis | SniperIQ
Labixiaoxin Snacks Group (1262) is a CN-listed Consumer Defensive company in Packaged Foods with a market capitalization of HK$749M, trading at HK
Labixiaoxin Snacks Group (1262) has a market capitalization of approximately HK$749M, trading at HK
Labixiaoxin Snacks Group's trailing twelve-month P/E ratio is 49.8x, with a price-to-book (P/B) of 2.6x. Valuation multiples are best compared with Consumer Defensive sector peers rather than read in isolation.
Labixiaoxin Snacks Group runs a net profit margin of 1.2%, a gross margin of 27.5%, and an operating margin of 3.1%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
Labixiaoxin Snacks Group reported revenue of ¥970M for fiscal year 2025, with net income of ¥12M and earnings per share (EPS) of 0.0543. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Labixiaoxin Snacks Group does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Labixiaoxin Snacks Group carries a debt-to-equity ratio of 2.32x and a current ratio of 0.74x, with a market beta of 0.39. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Labixiaoxin Snacks Group (1262) the key facts are: market cap HK$749M, P/E 49.8x, revenue ¥970M, 52-week range 1.53-4.88. Weigh valuation, profitability, growth, and balance-sheet strength against Consumer Defensive peers and form your own view.
Get Labixiaoxin Snacks Group's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.